This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Austin, H. Articles by Shingleton, H. M. Search for Related Content PubMed PubMed Citation Articles by Austin, H. Articles by Shingleton, H. M.

Endometrial Cancer, Obesity, and Body Fat Distribution¹

Department of Epidemiology, School of Public Health, University of Alabama at Birmingham 35294 [H. A.]; Department of Obstetrics and Gynecology, University of Alabama at Birmingham 35294 [E. E. P., K. D. H., H. M. S.]; and Southern Gyn Oncology, Birmingham [J. M. A.], Alabama 35205

A case-control study was undertaken to evaluate the roles of obesity and body fat distribution in the etiology of endometrial cancer. The study also included an evaluation of the associations of serum estrone, estradiol, and androstenedione with obesity, body fat distribution, and endometrial cancer risk. The study included 168 cases and 334 control subjects identified at an optometry clinic.

A strong, positive relationship between overall obesity and endometrial cancer was found. The relative rate of endometrial cancer for women in the upper 90th percentile of a body mass index compared to those below the median was estimated as 5.5 with 95% confidence limits of 3.2–9.6. There was no association between endometrial cancer and the waist to hip ratio, an index of upper versus lower body fat distribution. A statistical test of trend across the four quartiles of the waist to hip ratio yielded a P value of 0.45 after adjustment for confounding by the body mass index. On the other hand, there was a statistically significant, independent positive effect of a high subscapular to tricep skinfold ratio, a measure of central versus peripheral obesity, on endometrial cancer risk. The relative rates of endometrial cancer for the second, third, or fourth quartile compared to the first quartile of this index were 1.5, 1.9, and 2.7, respectively (P = 0.007), after adjustment for the body mass index.

Serum estrone and estradiol, but not androstenedione, were statistically significantly correlated with the body mass index among control subjects (r = 0.37 and 0.40 for estrone and estradiol, respectively). On the other hand, each of the sex hormones was uncorrelated with the waist to hip ratio after adjustment for body mass. The correlations between each of the three hormones and the subscapular to tricep skinfold ratio among controls were weak and were not statistically significant (0.10, 0.10, and 0.14 for estrone, estradiol and androstenedione, respectively). Cases had statistically significantly higher mean serum estrogen and androstenedione levels than did controls and these elevations did not simply reflect a higher prevalence of obesity among them.

The findings are equivocal with respect to fat patterns and endometrial cancer. We suggest that future epidemiological studies of cancer and body fat distribution more carefully distinguish among the various types of fat patterns.

¹ Supported by a grant from the National Cancer Institute (Ro1-CA39733).

² To whom requests for reprints should be addressed, at 202 Tidwell Hall, School of Public Health, University Station, Birmingham, AL 35294.

Received 6/11/90. Accepted 10/25/90.

This article has been cited by other articles:

				N. E Allen, T. J Key, L. Dossus, S. Rinaldi, A. Cust, A. Lukanova, P. H Peeters, N C. Onland-Moret, P. H Lahmann, F. Berrino, et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC) Endocr. Relat. Cancer, June 1, 2008; 15(2): 485 - 497. [Abstract] [Full Text] [PDF]

				M. L. McCullough, A. V. Patel, R. Patel, C. Rodriguez, H. S. Feigelson, E. V. Bandera, T. Gansler, M. J. Thun, and E. E. Calle Body Mass and Endometrial Cancer Risk by Hormone Replacement Therapy and Cancer Subtype Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 73 - 79. [Abstract] [Full Text] [PDF]

				W. H. Xu, Y. B. Xiang, W. Zheng, X. Zhang, Z. X. Ruan, J. R. Cheng, Y.-T. Gao, and X.-O. Shu Weight history and risk of endometrial cancer among Chinese women Int. J. Epidemiol., February 1, 2006; 35(1): 159 - 166. [Abstract] [Full Text] [PDF]

				F. Modugno, R. B. Ness, C. Chen, and N. S. Weiss Inflammation and Endometrial Cancer: A Hypothesis Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2840 - 2847. [Abstract] [Full Text] [PDF]

				W. H. Xu, C. E. Matthews, Y. B. Xiang, W. Zheng, Z. X. Ruan, J. R. Cheng, Y. T. Gao, and X. O. Shu Effect of Adiposity and Fat Distribution on Endometrial Cancer Risk in Shanghai Women Am. J. Epidemiol., May 15, 2005; 161(10): 939 - 947. [Abstract] [Full Text] [PDF]

				J. Vrbikova and D. Cibula Combined oral contraceptives in the treatment of polycystic ovary syndrome Hum. Reprod. Update, May 1, 2005; 11(3): 277 - 291. [Abstract] [Full Text] [PDF]

				M. S. Sothern and S. T. Gordon Prevention of Obesity in Young Children: A Critical Challenge for Medical Professionals Clinical Pediatrics, March 1, 2003; 42(2): 101 - 111. [PDF]

				R. Kaaks, A. Lukanova, and M. S. Kurzer Obesity, Endogenous Hormones, and Endometrial Cancer Risk: A Synthetic Review Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1531 - 1543. [Abstract] [Full Text] [PDF]

				R. KAAKS and A. LUKANOVA Effects of Weight Control and Physical Activity in Cancer Prevention: Role of Endogenous Hormone Metabolism Ann. N.Y. Acad. Sci., June 1, 2002; 963(1): 268 - 281. [Abstract] [Full Text] [PDF]

				G. E. Hale, C. L. Hughes, and J. M. Cline Endometrial Cancer: Hormonal Factors, the Perimenopausal ""Window of Risk,"" and Isoflavones J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 3 - 15. [Abstract] [Full Text] [PDF]

				A. AKHMEDKHANOV, A. ZELENIUCH-JACQUOTTE, and P. TONIOLO Role of Exogenous and Endogenous Hormones in Endometrial Cancer: Review of the Evidence and Research Perspectives Ann. N.Y. Acad. Sci., September 1, 2001; 943(1): 296 - 315. [Abstract] [Full Text] [PDF]

				R. A. Smith, A. C. von Eschenbach, R. Wender, B. Levin, T. Byers, D. Rothenberger, D. Brooks, W. Creasman, C. Cohen, C. Runowicz, et al. American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001--Testing for Early Lung Cancer Detection CA Cancer J Clin, January 1, 2001; 51(1): 38 - 75. [Abstract] [Full Text] [PDF]

				W. C. Willett Diet and Cancer Oncologist, October 1, 2000; 5(5): 393 - 404. [Abstract] [Full Text]

				K. O. Klein, K. A. Larmore, E. de Lancey, J. M. Brown, R. V. Considine, and S. G. Hassink Effect of Obesity on Estradiol Level, and Its Relationship to Leptin, Bone Maturation, and Bone Mineral Density in Children J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3469 - 3475. [Abstract] [Full Text]